Table 3.
Compound | Percentage of displacement of [125I]-1, relative to unlabeled peptide 1, ±SEM | p-Value |
---|---|---|
[(3R)-Agl3]-1 | 83.55 ± 9.02 | 0.9908 |
[(3R,4S)-Hgl3]-1* | 32.13 ± 16.94 | 0.0011 |
[(3R,4R)-Hgl3]-1 | 104.6 ± 6.826 | 0.9997 |
[(3R)-Agl3-(S)-Val4]-1 | 120.7 ± 15.69 | 0.954 |
[(3R,4S)-Hgl3-(S)-Val4]-1 | 58.63 ± 13.45 | 0.0724 |
[(3R,4R)-Hgl3-(S)-Val4]-1 | 82.12 ± 14.12 | 0.9308 |
[(3S)-Agl3]-1 | 106.6 ± 12.39 | 0.9996 |
[(3S,4R)-Hgl3]-1 | 78.64 ± 21.22 | 0.9428 |
[(3S,4S)-Hgl3]-1 | 69.73 ± 8.897 | 0.2864 |
[(3S)-Agl3-(S)-Val4]-1 | 102.7 ± 8.637 | 0.9999 |
[(3S,4R)-Hgl3-(S)-Val4]-1 | 48.32 ± 21.13 | 0.0649 |
[(3S,4S)-Hgl3-(S)-Val4]-1 | 86.06 ± 6.46 | 0.9806 |
p < 0.05 relative to cold peptide 1-treated group.